Back to Search Start Over

Epigenetic control of hypoxia inducible factor-1α-dependent expression of placental growth factor in hypoxic conditions

Authors :
Valeria Tarallo
Maurizio D'Esposito
Laura Tudisco
Sandro De Falco
Maria R. Matarazzo
Floriana Della Ragione
Ivana Apicella
Source :
Epigenetics 9 (2014): 600–610. doi:10.4161/epi.27835, info:cnr-pdr/source/autori:Tudisco L.; Della Ragione F.; Tarallo V.; Apicella I.; D'Esposito M.; Matarazzo M.R.; De Falco S./titolo:Epigenetic control of hypoxia inducible factor-1?-dependent expression of placental growth factor in hypoxic conditions/doi:10.4161%2Fepi.27835/rivista:Epigenetics/anno:2014/pagina_da:600/pagina_a:610/intervallo_pagine:600–610/volume:9
Publication Year :
2014
Publisher :
Informa UK Limited, 2014.

Abstract

Hypoxia plays a crucial role in the angiogenic switch, modulating a large set of genes mainly through the activation of hypoxia-inducible factor (HIF) transcriptional complex. Endothelial cells play a central role in new vessels formation and express placental growth factor (PlGF), a member of vascular endothelial growth factor (VEGF) family, mainly involved in pathological angiogenesis. Despite several observations suggest a hypoxia-mediated positive modulation of PlGF, the molecular mechanism governing this regulation has not been fully elucidated. We decided to investigate if epigenetic modifications are involved in hypoxia-induced PlGF expression. We report that PlGF expression was induced in cultured human and mouse endothelial cells exposed to hypoxia (1% O 2), although DNA methylation at the Plgf CpG-island remains unchanged. Remarkably, robust hyperacetylation of histones H3 and H4 was observed in the second intron of Plgf, where hypoxia responsive elements (HREs), never described before, are located. HIF-1?, but not HIF-2?, binds to identified HREs. Noteworthy, only HIF-1? silencing fully inhibited PlGF upregulation. These results formally demonstrate a direct involvement of HIF-1? in the upregulation of PlGF expression in hypoxia through chromatin remodeling of HREs sites. Therefore, PlGF may be considered one of the putative targets of anti-HIF therapeutic applications.

Details

ISSN :
15592308 and 15592294
Volume :
9
Database :
OpenAIRE
Journal :
Epigenetics
Accession number :
edsair.doi.dedup.....9cdacc9e482be218d31dab73da98f36f
Full Text :
https://doi.org/10.4161/epi.27835